N/A
N=109
Self-Management Interventions for Chronic Pain Relief With Cancer Survivors
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT03867760 ↗Enrolled (actual)
109
Serious AEs
0.0%
Results posted
Oct 2022
Primary outcome: Primary: Change in Pain Intensity — -1.61; -1.35 score on a scale — p=0.809
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Recorded Hypnosis Intervention (Behavioral); Recorded Relaxation Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Aug 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Intensity |
-1.61; -1.35 | 0.809 |
| SECONDARY Change in Pain Interference |
-3.75; -3.03 | 0.369 |
| SECONDARY Change in Anxiety |
-3.07; -3.61 | 0.029 sig |
| SECONDARY Change in Depression |
-1.75; -2.74 | 0.236 |
| SECONDARY Change in Fatigue |
-2.66; -2.67 | 0.904 |
| SECONDARY Change in Sleep Disturbance |
-3.96; -3.31 | 0.936 |
Summary
Cancer survivors who suffer from chronic pain would benefit from a low-cost, self-management intervention they can use at home. This study will evaluate the efficacy of a recorded hypnosis intervention in reducing chronic pain among cancer survivors and will explore its biological and psychological mechanisms.
Eligibility Criteria
Inclusion Criteria
- self-reporting moderate or higher pain on average during the last week (> 3 on a 0-10 pain intensity numeric scale)
- self-reporting experiencing pain at least half of the days in the past 4 weeks
- self-reporting chronic pain related to cancer or its treatment
- completed active cancer treatment other than maintenance therapy
- being > 18 years of age
- functional fluency in English
- mentally and physically able to participate and complete surveys
Exclusion Criteria
- has a psychiatric condition or symptoms (i.e., diagnosis of paranoid schizophrenia or active paranoid delusional thoughts, as determined via a telephone or in-person screening assessment) that would interfere with study participation.
Exclusion Criteria for Optional EEG Measurement:
- a history of seizure condition within the last year
- a significant brain injury or skull defect
- a history of brain cancer.
Data sourced from ClinicalTrials.gov (NCT03867760). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.